Skip to content

Immediate analgesic effects of cheek acupuncture for acute gouty arthritis: protocol for a randomised controlled trial

Immediate analgesic effects of cheek acupuncture for acute gouty arthritis: protocol for a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054396
Enrollment
Unknown
Registered
2021-12-17
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute gouty arthritis

Interventions

Experimental group:cheek acupuncture
Control group:oral etoricoxib

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the AGA diagnostic criteria of western medicine and suffer from unilateral ankle or first metatarsophalangeal joint attack; 2. Aged 18 to 75 years, male or female; 3. The patient's disease is within 48 hours of the onset of AGA; 4. The person who visited the doctor for the first time for this AGA attack and did not receive targeted external therapy or self-administered drugs including colchicine, anti-inflammatory and analgesic drugs, hormones, traditional Chinese medicine, etc.; 5. Willing to obey the doctor's treatment plan and cooperate with follow-up.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Those who are participating in other similar interventions; 3. Combined with severe liver and kidney insufficiency, cardiovascular and cerebrovascular diseases, tumors, blood system diseases, diabetes, hypertension, etc.; 4. Psychiatric patients who cannot understand the nature and scope of the research or who cannot comply with the doctor's orders; 5. Allergic to any component of traditional Chinese medicine or Western medicine; 6. Patients with active peptic ulcer/bleeding, or previous recurrence of ulcer/bleeding; 7. Patients who have induced asthma, urticaria or allergic reactions after taking aspirin or other non-steroidal anti-inflammatory drugs; 8. Congestive heart failure (New York Heart Association [NYHA] functional class II-IV).

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scoring;joint tenderness;mobility impairment;Patient feedback on this treatment;Immediate pain relief;

Countries

China

Contacts

Public ContactLin Yuping

Guangdong Provincial Hospital of Traditional Chinese Medicine

396277116@qq.com+86 13570459624

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026